AU2011100789A4 - The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism - Google Patents

The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism

Info

Publication number
AU2011100789A4
AU2011100789A4 AU2011100789A AU2011100789A AU2011100789A4 AU 2011100789 A4 AU2011100789 A4 AU 2011100789A4 AU 2011100789 A AU2011100789 A AU 2011100789A AU 2011100789 A AU2011100789 A AU 2011100789A AU 2011100789 A4 AU2011100789 A4 AU 2011100789A4
Authority
AU
Australia
Prior art keywords
inflammatory
auto
cases
emu oil
hypothyroidism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011100789A
Inventor
Rayyar Farhat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farhat Rayyar Miss
Original Assignee
Farhat Rayyar Miss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farhat Rayyar Miss filed Critical Farhat Rayyar Miss
Priority to AU2011100789A priority Critical patent/AU2011100789A4/en
Application granted granted Critical
Publication of AU2011100789A4 publication Critical patent/AU2011100789A4/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)

Abstract

2011100789 The use of emu oil as an internal anti-inflammatory for the reduction of pain and the reduction of inflammation of the thyroid in cases of auto-immune hypothyroidism, by the oral ingestion of emu oil.

Description

1 Description the use of emu oil as an internal anti-inflammatory for the reduction of pain and reduction of inflammation of the thyroid in cases of auto-immune hypothyroidism, by the oral ingestion of emu oil the use of emu oil as an internal anti-inflammatory for the reduction of pain and reduction of inflammation of the thyroid in cases of auto-immune hypothyroidism, by the oral ingestion of emu oil
AU2011100789A 2011-06-30 2011-06-30 The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism Ceased AU2011100789A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2011100789A AU2011100789A4 (en) 2011-06-30 2011-06-30 The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2011100789A AU2011100789A4 (en) 2011-06-30 2011-06-30 The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism

Publications (1)

Publication Number Publication Date
AU2011100789A4 true AU2011100789A4 (en) 2011-09-01

Family

ID=45421149

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011100789A Ceased AU2011100789A4 (en) 2011-06-30 2011-06-30 The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism

Country Status (1)

Country Link
AU (1) AU2011100789A4 (en)

Similar Documents

Publication Publication Date Title
TW200800987A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
GB201020860D0 (en) Disulfiram formulation and uses thereof
EA201300530A1 (en) ANTIBODIES TO IL-23
EP3004595A4 (en) Turbofan engine bearing and gearbox arrangement
NZ596916A (en) Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
MX354137B (en) Topical minocycline compositions and methods of using the same.
EA201001845A1 (en) HIGH EFFICIENCY ANTI-OXIDANT BASED ON TRIGULOSE
WO2011083483A3 (en) Method for treatment of inflammatory disease and disorder
TW200716577A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
WO2015003021A3 (en) Dietary supplements and composition for treating cancer
TW200716581A (en) Benzothiazol-2-one derivatives as inhibitors of lipases and phospholipases
MX2016008209A (en) Oral care compositions and methods.
AU2011100789A4 (en) The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism
WO2011019867A3 (en) Dietary supplements and methods for treating pain and inflammation
MX354872B (en) Oral care compositions and methods.
GB201210666D0 (en) Turbocharger mounting apparatus
WO2012125552A3 (en) Methods of electric field induced delivery of compounds, compositions used in delivery, and system of delivery
WO2012018980A3 (en) Compositions and methods for treating inflammatory diseases
WO2013173803A3 (en) Formulations of amoxicillin and clavulanate potassium and methods for using same
CA2888728C (en) Compounds combining an aminopeptidase n inhibitor and a neprilysin inhibitor through the intermediary of a cleavable disulfide bridge in vivo
MX356027B (en) Oral care compositions and methods.
CR20130288A (en) COMPRESSED PHARMACEUTICAL CONTROLLED RELEASE FOR ORAL ADMINISTRATION
WANDI et al. China's CSR on the Global Market Fast Track——An Interview with Xu Zongxiang, vice president of China South Locomotive & Rolling Stock Corporation Limited (CSR)
UA81797U (en) Method for preventing complications in cats following use of oral contraceptives
RIKY The Relationship Of Corporate Social Responbility Disclosure On Company Financial Performance

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK21 Patent ceased section 101c(b)/section 143a(c)/reg. 9a.4 - examination under section 101b had not been carried out within the period prescribed